fashion -WSS

fashion

author：Wikipedia 2025-10-02 01:08:02 - browse：1

Senate Health, Education, Labor, and Pensions Committee Chairman Bernie Sanders looks at Moderna CEO Stephane Bancel as he testifies. Sitting next to Sanders, ranking member Sen. Bill Cassidy looks down – policy coverage from STAT — Committee Ranking Republican Bill Cassidy (La.) and Chairman Bernie Sanders (I-Vt.) Chip Somodevilla/Getty Images

WASHINGTON – The Senate health committee on Thursday passed a package of bills aimed at speeding generic drug competition and reining in drug middlemen business practices. But they failed to pass an ambitious reform to the pharmacy benefit manager sector, despite strong bipartisan support for it.

Chairman Bernie Sanders (I-Vt.) is pursuing the drug pricing reforms at the behest of Senate Majority Leader Chuck Schumer (D-N.Y.), who wants to hold a floor vote on an even bigger package of health bills later this year. The markup came just a day after the same panel held a major hearing on PBM and drugmakers’ role in high insulin prices.

It’s not clear when the Senate would take up that package, and while the package is bipartisan, it’s not clear whether it has enough support among House Republicans to pass in that chamber. There are a few, tamer PBM bills that the House Energy and Commerce Committee is expected to mark up May 17, but there is no indication that Senate and House lawmakers are coordinating on PBM legislation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： New Medicare drug pricing powers could soon be upended in court

explore

WSS

Change Healthcare can notify patients about the breach, HHS says

Heart disease and mental health: A look at cardiac psychology

HHS names first

Risky weight loss products often used by teens globally, per study

New England Journal of Medicine addresses racist history, slavery

Shifting the focus from loneliness to social health

focus

fashion

hotspot

Apple is now the first public company to be valued at $3 trillion

Ionis drug prevents swelling attacks due to hereditary angioedema

Supreme Court strikes down use of affirmative action

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Apple is now the first public company to be valued at $3 trillion

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Anesthesiologist group: stop taking Ozempic before surgery

DeSantis can now import cheaper drugs. But will Biden get credit?

hotspot

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Woman returns to dialysis after doctors remove transplanted pig kidney

Designating disabled people as health disparity population is crucial

Woman returns to dialysis after doctors remove transplanted pig kidney

knowledge

focus

explore

leisure time